What dose of olanzapine is equivalent to clozapine 100 mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Dose Equivalence: Clozapine 100mg to Olanzapine

Clozapine 100mg is approximately equivalent to olanzapine 2.5mg based on the most rigorous dose equivalence methodology available.

Evidence-Based Conversion

Using the minimum effective dose method, which is the most operationalized and evidence-based approach for determining antipsychotic dose equivalence, the conversion is derived as follows 1:

  • Clozapine minimum effective dose: 300mg daily
  • Olanzapine minimum effective dose: 7.5mg daily
  • Olanzapine equivalent for clozapine 300mg: 40

Therefore:

  • Clozapine 100mg = Olanzapine 2.5mg (100mg ÷ 300mg × 7.5mg = 2.5mg)

Important Clinical Context

Why This Conversion May Be Misleading

This mathematical equivalence does NOT mean these doses are clinically interchangeable. The conversion ratio is based on minimum effective doses for treating positive symptoms in non-refractory schizophrenia, but several critical factors make direct substitution problematic:

1. Treatment-Resistant Schizophrenia Considerations:

  • Clozapine remains the gold standard for treatment-resistant schizophrenia (TRS) and is recommended after failure of at least two adequate antipsychotic trials 2
  • Recent meta-analyses show clozapine demonstrates significant superiority over high-dose olanzapine (≥20mg/day) specifically for positive symptoms (MD = -1.30,95% CI [-2.52, -0.08]) in TRS populations 3
  • No significant differences exist for overall psychopathology or negative symptoms between the two agents 3

2. Distinct Pharmacological Profiles:

  • Clozapine has unique receptor binding: D2 (Ki 160 nM), with high affinity for histamine H1 (Ki 1.1 nM), α1A (Ki 1.6 nM), and muscarinic M1 (Ki 6.2 nM) 4
  • The therapeutic mechanism extends beyond simple D2 antagonism, involving multiple receptor systems that cannot be replicated by dose adjustment alone

3. Different Side Effect Profiles:

  • Clozapine: Higher risk of agranulocytosis (requires hematological monitoring), more pronounced triglyceride elevation, higher dropout rates due to adverse effects 5
  • Olanzapine: Some studies show significantly greater weight gain at high doses (≥20mg/day) compared to clozapine (15.9 vs 3.5 lbs), but better general tolerability 3
  • Both require metabolic monitoring, with metformin recommended as adjunctive treatment 2

Clinical Application Algorithm

When considering switching between these medications:

  1. If patient is on clozapine for TRS: Do not switch to olanzapine based on dose equivalence alone, as clozapine has superior efficacy for positive symptoms in this population 3

  2. If switching FROM clozapine TO olanzapine (e.g., due to intolerance):

    • Use gradual cross-titration informed by half-life and receptor profiles 2
    • Consider high-dose olanzapine (≥20mg/day) as the comparator dose range, not the mathematical equivalent of 2.5mg
    • Monitor closely for symptom re-emergence, particularly positive symptoms
  3. If switching FROM olanzapine TO clozapine (e.g., treatment resistance):

    • Clozapine should be titrated based on therapeutic response and plasma levels (target ≥350 ng/mL), not based on prior olanzapine dose 2
    • Offer concurrent metformin to attenuate weight gain 2
    • Standard clozapine titration protocols apply regardless of prior antipsychotic dose

Critical Caveats

  • The 100mg:2.5mg ratio is NOT applicable to treatment-resistant or first-episode populations 1
  • Dose equivalence calculations are useful for research purposes and general guidance but should not dictate individual clinical decisions
  • Plasma level monitoring for clozapine (target 350-550 ng/mL) is more clinically relevant than dose equivalence calculations 2
  • The minimum effective dose method has limitations and alternative methods exist, though this represents the most operationalized approach currently available 1

Related Questions

What is the maximum duration olanzapine can be used as a bridge therapy in place of clozapine when clozapine is unavailable?
Can clozapine be co-administered with olanzapine?
In a 41‑year‑old patient with an unspecified mood disorder taking Auvelity (dextromethorphan‑bupropion) 45‑105 mg daily and Caplyta (lumateperone) 10.5 mg daily, who has anemia (low RBC, low hemoglobin, low hematocrit), elevated fasting glucose, high blood urea nitrogen with mildly elevated creatinine, normal liver enzymes, and normal thyroid‑stimulating hormone, what is the appropriate work‑up and management?
For a patient on aripiprazole (Abilify) 10 mg daily and fluoxetine 20 mg daily who is experiencing auditory hallucinations upon waking and in the evening with increasing frustration, should the aripiprazole dose be increased to 15 mg or 20 mg?
In a 72‑year‑old patient taking bupropion (Wellbutrin) 450 mg daily, how should fluoxetine (Prozac) 20 mg be added and what monitoring is required?
What are the possible causes of mild elevation of aspartate aminotransferase (AST) and alanine aminotransferase (ALT)?
What are the causes of significant stenosis of the distal posterior tibial artery?
What is the appropriate immediate management for accidental topical application of 5-fluorouracil (5‑FU) to the scrotal skin?
What is the maximum duration olanzapine can be used as a bridge therapy in place of clozapine when clozapine is unavailable?
Can a patient taking magnesium glycinate (magnesium glycinate) take it with budesonide/formoterol (Veozah) without separating doses, and what is the recommended dosage and timing?
Is Augmentin (amoxicillin/clavulanate) safe for a kidney‑transplant recipient who is four years post‑transplant?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.